Articles tagged with Eye Diseases
Researchers at the NIH developed eye drops containing a short peptide derived from PEDF, which slowed photoreceptor degeneration and vision loss in animal models of retinitis pigmentosa and dry age-related macular degeneration. The treatment preserved up to 75% of photoreceptors and showed no negative side effects.
A Northwestern University study found significant disparities in glaucoma monitoring, with rural and economically distressed communities facing barriers to care. The study identified strategies to improve access, including expanding tele-ophthalmology services, home monitoring technology, and financial support.
Researchers have successfully developed lab-grown pig retinal organoids, which shared similarities with human retinal organoids. The study offers a promising approach to combatting retinal disease by testing 'human-equivalent' photoreceptors in pigs.
Researchers emphasize the importance of regular screenings and treatment to prevent vision loss in patients with diabetes. Current guidelines recommend eye exams for adults with type 1 and type 2 diabetes, while adolescents and young adults are at higher risk due to difficulty controlling their condition.
A new study explores how wild animals can provide insights into novel biomedical breakthroughs. Researchers have discovered that deep-sea worms, hibernating bears, and king penguins possess unique traits that could lead to effective treatments against antibiotic-resistant infections and lifestyle diseases.
A new diagnostic method called flicker optoretinography (f-ORG) analyzes the retina's reaction to light, helping to detect danger before symptoms appear. The technique detects even minor changes in photoreceptors, providing valuable insights into retinal health.
A new stem cell therapy, CALEC, has been successfully tested on 14 patients with blinding cornea injuries, achieving a high proportion of complete or partial success rates. The treatment was found to be safe and effective, with no serious events occurring in either the donor or recipient eyes.
The AI-GS network achieves high accuracy with 93.52% sensitivity at 95% specificity, excelling in detecting early-stage glaucoma. The system is portable, requiring minimal computational power and delivering results in under a second.
Scientists have identified key corneal neurons involved in sensitivity and developed an experimental model to study nerve regeneration. The Ocular Neurobiology laboratory is participating in the RESTORE VISION project, which aims to improve eye health and quality of life for those affected by rare eye diseases.
A team of scientists at Indiana University School of Medicine has identified a potential link between retinal changes and Alzheimer's disease. The study found that the APOE4 gene variant impairs retinal function in mice, suggesting a direct link to visual processing deficits associated with Alzheimer's disease.
A Mount Sinai-led research team has identified stem cell populations and mechanisms underlying age-related degeneration in meibomian glands, which secrete lipid-rich meibum to prevent tear evaporation. The findings suggest that targeting Hh and EGFR signaling could be a potential therapeutic option for evaporative dry eye disease.
Researchers at Karolinska Institutet discovered a fundamental mechanism linking breathing to pupil size, which affects vision. The study shows that the pupil is smallest during inhalation and largest during exhalation, impacting visual perception.
A study analyzing 12 sunglasses models found that only one met international safety limits for UV radiation exposure. The lenses lose their ability to block UV radiation over time, increasing the risk of eye damage. To minimize this risk, scientists suggest adopting ICNIRP limits as standard practice.
A new genetic medicine has been developed to treat a rare genetic deficiency affecting the AIPL1 gene, causing severe retinal dystrophy. The treatment involves injecting healthy copies of the gene into the retina through keyhole surgery, resulting in dramatic improvements in sight for four young children.
Researchers from JAX used mice with different genetic backgrounds to identify factors influencing eye aging, leading to a better understanding of age-related eye diseases. The study found that genetics play a key role in retinal aging and predicts common age-related eye diseases.
A recent study found that cold temperatures allow the bird pink eye pathogen to survive on bird feeders for up to seven days, causing more severe disease in birds compared to warmer temperatures. Regular cleaning of feeder surfaces with bleach can help mitigate the spread of the disease.
Researchers at Fujita Health University have developed a novel therapy using mesenchymal stem cells to treat inflammatory eye diseases, reducing inflammation and promoting tissue repair. The study found that adMSC injections effectively reduced inflammation in mice with GVHD without long-term complications.
A study found nine cases of vision problems in patients taking GLP-1 medications, with seven experiencing nonarteritic anterior ischemic optic neuropathy (NAION). Neuro-ophthalmologists warn of potential risks due to the increasing demand for these drugs, which can cause blood sugar fluctuations.
A new study analyzed 100 cases of Florida spot keratopathy (FSK), a condition characterized by white spots on the cornea. The research found that FSK is typically stable and does not significantly affect vision or quality of life, but may be linked to exposure to little fire ants.
Researchers at FAU's Schmidt College of Medicine will explore the use of genetically engineered cells to treat degenerative diseases, with a focus on understanding how hypoxic conditions drive cellular transformation. The study aims to identify novel pathways controlling this process and develop strategies for engineering more complex ...
Researchers have created detailed maps of the retina using AI technology to better understand its link to various diseases. The study identified new genetic factors influencing retinal thickness, which may serve as a diagnostic biomarker for disease detection.
Researchers found a genetic change, pR552*, that could give the RB1 gene a new function leading to cancer growth. This challenges the common belief that both copies of the RB1 gene must be damaged for cancer to develop.
Researchers at Mayo Clinic developed patient-derived organoid models to study uveal melanoma, a common type of eye cancer. These 3D models accurately represent the disease's genetic and biological characteristics, enabling better understanding and treatment development.
A study found that people with delayed REM sleep have higher levels of toxic proteins amyloid and tau, and lower levels of healthy protein BDNF, which can increase the risk of developing Alzheimer's. Practicing healthy sleep habits may help mitigate this risk.
Researchers found AI-based imaging technology improves disease diagnosis accuracy, particularly in cardiology, oncology, neurology, and ophthalmology. The technology also enhances diagnostic efficiency and reduces healthcare disparities by delivering high-quality diagnostics to underserved areas.
Researchers found that integrating optometrists into community clinics reduces patient wait times and lower costs for the NHS. Local optician practices handle conditions like nAMD and glaucoma, delivering quality care while optimizing resources.
A University of Houston study found that wearing multifocal contact lenses for myopia control has a lasting effect, slowing eye growth and progression. The study, which followed children from ages 7 to 11 for three years, showed that the treatment benefit remained even after discontinuing treatment.
Researchers found that time in safe blood-sugar range can predict diabetes complications as accurately as hemoglobin A1c levels. The study used advanced machine learning techniques to analyze landmark diabetes data from the DCCT trial.
A new study has identified genetic and demographic factors that increase the risk of developing age-related macular degeneration (AMD). The research found a significant difference in AMD risk between European and non-European descent populations, highlighting the importance of diverse ancestry groups in understanding this condition.
Two non-retinoid compounds were identified that improve cell surface expression of rhodopsin in 36 genetic subtypes of retinitis pigmentosa and protect against retinal degeneration in mice with the disease. The treatment showed improved overall retina health and function, prolonging photoreceptor survival.
A massive study of human protein variants found that 61% of disease-causing mutations destabilize proteins, leading to cataracts, neurological disorders, and muscle-wasting diseases. The researchers created the Human Domainome 1 catalogue, which includes over half a million mutations across 522 human protein domains.
A recent study has explored a new imaging approach that uses swept-source optical coherence tomography to visualize the upper airway with high precision. By integrating computational fluid dynamics, researchers were able to identify areas of turbulence and pinpoint obstruction sites, leading to more accurate diagnoses and treatment pla...
A new study reveals that the vestibulo-ocular reflex, which enables stable perception of surroundings, matures without sensory input in newborns. Researchers discovered that the slowest-maturing part of the brain circuit is at the neuromuscular junction, not in the brain as previously assumed.
A comprehensive analysis of medical AI technologies highlights their potential in improving diagnostic accuracy and customizing treatments. However, challenges such as data collection and analysis, biases, and patient privacy concerns need to be addressed through standardized evaluation protocols and effective collaborations.
Researchers used STOC-T to visualize retinal microcirculation in real-time, providing insights into the mechanisms of retinal function. The study offers a groundbreaking opportunity for precise monitoring of hemodynamic changes in the retina, enabling early detection and treatment of diseases such as Alzheimer's and Parkinson's.
Ocular immune-related diseases, including uveitis, diabetic retinopathy, age-related macular degeneration, and Graves' ophthalmopathy, are caused by abnormal immune inflammatory responses. The review highlights the role of microglia and other macrophages in these conditions, providing new target cells for prevention and treatment.
Two independent studies from University of Southern Denmark confirm that patients with type 2 diabetes who take Ozempic are at increased risk of developing damage to the optic nerve, leading to severe and permanent loss of vision. The risk doubles compared to those not taking Ozempic.
A new study published in Lancet Gastroenterology and Hepatology found that a combined screening approach can detect liver damage in people with type 2 diabetes. The method involves elastography, an ultrasound-based technique, which was found to be willing to be adopted by most patients. Early detection of liver fibrosis is crucial, as ...
A research team led by USC aims to create comprehensive maps of retinal nerve connections to understand and combat retinitis pigmentosa, a progressive eye disease affecting 2 million people globally.
The University of Colorado Anschutz Medical Campus is developing a groundbreaking treatment for total blindness using whole eye transplantation. The $46 million award from ARPA-H will support research aimed at restoring vision to patients with total blindness.
Researchers at Mass Eye and Ear developed an mRNA-based therapy to prevent scarring and blindness in PVR. The treatment, called RUNX1-Trap, targets a protein that regulates scar tissue formation, showing early promise for treating this eye disease.
Researchers have discovered two human antibodies that can recognize and target proteins causing severe malaria. These broadly reactive antibodies may represent a common mechanism of acquired immunity to severe malaria, offering insights for the design of a PfEMP1-based vaccine or treatment targeting severe malaria. The breakthrough cou...
A team of researchers has identified a mechanism that interferes with the splicing process in a more subtle way, leading to cell death. The study reveals that spliceosome subunits U4, U5, and U6 are normally stabilized by protein USP39, but when mutated or absent, stability is compromised, causing incorrect connections during splicing.
A phase 3 clinical trial has demonstrated that inebilizumab significantly reduced the risk of symptoms in patients with immunoglobulin G4-related disease (IgG4-RD) by 87%. The treatment, which depletes CD19-expressing B cells, shows promise for improving patient outcomes and reducing the need for immunosuppressive treatment.
Researchers from Indiana University have uncovered how the EphA2 protein receptor contributes to cataract formation. The study found that canonical ligand-dependent EphA2 signaling remains stable in aging lens tissue, while non-canonical signaling increases with age, affecting lens fiber cell maturation.
A new scientific statement highlights improvements in diagnosis, initial treatment, and long-term management of patients with Kawasaki Disease, emphasizing the need for tailored management strategies. Advances in cardiac imaging techniques and risk categorization have led to better patient outcomes.
A study reveals racial disparities in genetic detection rates for inherited retinal diseases, with lower rates observed in Black patients compared to white patients. The findings highlight the need for improved genetic testing and therapeutic development to address these disparities.
Researchers have identified a new experimental drug that can bridge the gap between patients with wet age-related macular degeneration (AMD) and existing treatments. The drug, 32-134D, decreases levels of a key protein involved in AMD, leading to improved vision outcomes.
Researchers at Rensselaer Polytechnic Institute have developed a novel compound to treat dry age-related macular degeneration and Stargardt disease, both blindness-causing diseases. The compound has shown therapeutic potential in slowing down disease progression and preserving vision.
A new study found that long-term, low-dose valacyclovir treatment significantly reduces the risk of vision-damaging bouts of inflammation and infection in patients with shingles. Participants treated for a year saw a 26% reduction in eye disease flare-ups at 18 months.
Researchers found that using valacyclovir for a year can decrease the risk of new or worsening eye disease and prevent vision loss associated with shingles. The study, which enrolled over 500 participants, showed that this treatment reduced the risk of complications by 30%.
Researchers have identified shared critical pathways in retinitis pigmentosa disease models using advanced proteomics techniques. This study suggests that disease-modifying treatments could benefit patients with all forms of the disease, regardless of the underlying mutation.
Researchers have successfully transplanted human embryonic stem cell-derived retinal organoid sheets into monkeys with macular holes, resulting in graft survival and maturation of light-detecting cells. The study suggests that this method could become a practical treatment option for difficult macular hole cases.
Researchers identified a crucial protein, TIMP3, overproduced in AMD and found that blocking its activity can reduce drusen formation, suggesting a promising treatment strategy. The study offers new avenues for preventing AMD and improving the lives of millions affected by this disease.
Researchers at Arizona State University have developed new diagnostic tools using artificial intelligence (AI) to help identify myopic maculopathy, a serious eye condition. The AI-powered systems can analyze retinal images and predict the correct classification of the disease, enabling more accurate treatment recommendations.
Researchers have discovered a gene responsible for some inherited retinal diseases, which damage the retina and threaten vision. The study identified the UBAP1L gene as a cause of different forms of retinal dystrophy, including maculopathy and cone-rod dystrophy, affecting central and night vision.
A UD researcher has received a $2.3M NIH grant to investigate inherited retinal diseases. The funding will support groundbreaking research that could lead to significant breakthroughs in understanding and addressing these conditions.
Researchers at UCL Institute of Ophthalmology have revealed the molecular mechanisms behind FECD, a leading cause of vision loss in older adults. The study found that extreme genetic instability plays a key role in the disease's progression.
A University of Houston team developed non-invasive, comfortable, and safe wearable sensors to monitor eyeball movements, providing early warning signs of brain-related disorders. The new sensors have potential applications in diagnosing conditions like ADHD, autism, Alzheimer's disease, Parkinson's disease, and traumatic brain injuries.
Researchers aim to find a new treatment pathway for diabetic retinopathy by targeting the IL-6 protein. They suspect that selectively inhibiting trans-signaling while allowing cis-signaling will stop damage and restore balance in the retina.